Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haematology.

A Fletcher1

  • 1St James's Hospital, Leeds Teaching Hospital Trust, Leed LS9 7TF. Andrew.Fletcher@leedsth.nhs.uk

Journal of the Royal Army Medical Corps
|May 19, 2007
PubMed
Summary
This summary is machine-generated.

Recent advances in hematology focus on managing chemotherapy side effects and late treatment effects. New therapies targeting altered malignant pathways show promise, alongside developments in iron chelation and hemostatic agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Returning to education after childhood acquired brain injury: Learning from lived parental experience.

NeuroRehabilitation·2023
Same author

Understanding further education as a context for public health intervention: qualitative findings from a study process evaluation.

Journal of public health (Oxford, England)·2019
Same author

Multimodality quantitative assessments of myocardial perfusion using dynamic contrast enhanced magnetic resonance and <sup>15</sup>O-labelled water positron emission tomography imaging.

IEEE transactions on radiation and plasma medical sciences·2018
Same author

Integrating modelling and phenotyping approaches to identify and screen complex traits: transpiration efficiency in cereals.

Journal of experimental botany·2018
Same author

Does integrated academic and health education prevent substance use? Systematic review and meta-analyses.

Child: care, health and development·2018
Same author

The influence of microsporidian pathogens from commercially available lady beetles on larval development of the green lacewing, Chrysoperla carnea, in the absence of infection.

Journal of invertebrate pathology·2018
Same journal

A tribute to the <i>Journal of the Royal Army Medical Corps</i>.

Journal of the Royal Army Medical Corps·2019
Same journal

Towards the future: The final issue of the journal of the Royal Army Medical Corps 1903-2019.

Journal of the Royal Army Medical Corps·2019
Same journal

Interests and concerns of the Army Medical Services as reflected by the publications in the <i>Journal of the Royal Army Medical Corps</i> 1903-2019.

Journal of the Royal Army Medical Corps·2019
Same journal

Dispatched from the Editor in Chief: does the impact factor have any real relevance to our military health journal?

Journal of the Royal Army Medical Corps·2019
Same journal

Highlights of the edition: the military medical ethics special issue.

Journal of the Royal Army Medical Corps·2019
Same journal

Aeromedical evacuation in the humanitarian and disaster relief environment of Op RUMAN.

Journal of the Royal Army Medical Corps·2019
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Effective chemotherapy has improved survival rates in hematological malignancies.
  • Late effects of treatments for hematological malignancies are emerging as a significant clinical challenge.
  • Understanding altered molecular pathways in hematological cancers drives therapeutic innovation.

Purpose of the Study:

  • To review recent advancements in both malignant and non-malignant hematology.
  • To discuss strategies for minimizing treatment side effects without compromising outcomes.
  • To examine the identification and management of late treatment effects.

Main Methods:

  • Review of current literature on hematological advances.
  • Discussion of therapeutic strategies, including stratification and enzyme activity monitoring.

Related Experiment Videos

  • Analysis of novel agents for iron chelation and hemostasis.

    • Main Results:

    • New therapies targeting specific molecular pathways demonstrate excellent results in hematological malignancies.
    • Focus is shifting towards managing long-term side effects and improving quality of life.
    • Novel iron chelators and activated factor VII offer new treatment possibilities.

    Conclusions:

    • Hematology is rapidly evolving, with a dual focus on treating malignancy and managing treatment-related toxicities.
    • Personalized medicine approaches, informed by pathway knowledge, are crucial.
    • Continued research into supportive care and novel agents is essential for improving patient outcomes.